About this trial
In the in vitro modeling phase, the investigators plan to use a realistic human upper respiratory tract model and an asymmetric ideal bronchial tree model. By combining 3D printing experiments with CFD simulations, the investigators will investigate the respiratory tract deposition rate and distribution of micro - moist particles in ultrasound rock salt aerosol inhalation therapy. This will be compared with a small - volume nebulizer to verify the effectiveness of ultrasound rock salt aerosol inhalation therapy and lay the foundation for further research on the application of this inhalation technique to other drug formulations.
In the clinical phase, the investigators plan to have subjects inhale radioactive aerosols and use PET/CT imaging technology to assess the deposition rate of aerosol particles in the lungs. By quantitatively analyzing the images, the investigators will study their distribution characteristics in real human bodies to verify the accuracy of the in vitro models and the potential for clinical application.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Crossover
Treatments tested in this trial
USN before SVN
DeviceThe group that received ultrasonic rock salt aerosol inhalation therapy followed by small-volume nebulized inhalation therapy.
SVN before USN
DeviceThe group that received small-volume nebulized inhalation therapy followed by ultrasonic rock salt aerosol inhalation therapy.
Treatment groups
Trial outcomes
Primary outcomes
In Vitro Model Pulmonary Deposition Rate
Aerosol lung deposition rate calculated by in vitro model
Pulmonary Drug Deposition Rate
Defined as the percentage of drug deposition in the lungs, relative to the whole inhalation volume
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Jingen Xia
Lead sponsor
China-Japan Friendship Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: